Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Basket Trial of Autologous Anti-GD2 CAR T Cells in Relapsed or Refractory GD2-Positive Solid Tumors
TCTR20251222009Phase 2Recruiting
- Sponsor
- Chiang Mai University
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 2, single-arm trial in Nonhematologic neoplasms, sponsored by Chiang Mai University. Started Jan 2026; status: recruiting.
02
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on TCTR20251222009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251222009.